APDN Stock: Why It Significantly Increased

By Amit Chowdhry ● Oct 13, 2021
  • The stock price of Applied DNA Sciences Inc (NASDAQ: APDN) increased by over 20% yesterday. This is why it happened.

The stock price of Applied DNA Sciences Inc (NASDAQ: APDN) – a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies – increased by over 20% yesterday. Investors are responding positively to Applied DNA Sciences announcing that safeCircle – its high-throughput pooled COVID-19 testing program – has been implemented at Sarah Lawrence College as an addition to the college’s in-house testing practice to monitor for the prevalence of COVID-19 during the Fall 2021 semester. 

The testing began this week and is available to asymptomatic students, faculty, and staff on a voluntary basis. And the college’s population of approximately 2,000 undergraduate and graduate students, faculty, and staff are required to be vaccinated against COVID-19.


“safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens. We see safeCircle as a complement to our vaccine mandate.”

— Mary Hartnett, Director of Medical Services at Sarah Lawrence College

“The increased transmissibility of the Delta variant, as well as the variant’s capacity to reduce the effectiveness of vaccines against infection, we believe, makes all the more compelling the need to test both vaccinated and unvaccinated populations. safeCircle’s approach to COVID-19 testing, the combination of a comprehensive managed services offering and self-service reporting and communications platform provided by our partner, CLEARED4, continues to resonate with institutes of higher education seeking to keep populations safe and campuses open. We applaud Sarah Lawrence College for making testing broadly available on its campus to asymptomatic employees and students.”

— Mike Munzer, executive director of Diagnostic Sales at Applied DNA

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.